http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2979823-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b58f981963f6d55d627139e778c4ef7b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553
filingDate 2011-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4497b434aa7d221c4c7ef5b126d1c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d064943c6a50c55bc18ac97c8a24d3fd
publicationDate 2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2979823-A1
titleOfInvention USE OF 3- (R) - [3- (2-METHOXYPHENYLTHIO) -2- (S) -METHYL-PROPYL] AMINO-3,4-DIHYDRO-2H-1,5-BENZOXATHIEPINE FOR THE TREATMENT OF CANCER AND IN PARTICULAR FOR THE PREVENTION AND / OR TREATMENT OF CANCER METASTASES
abstract The present invention relates to the use of 3- (R) - [3- (2-methoxyphenylthio) -2- (S) -methyl-propyl] amino-3,4-dihydro-2H-1,5-benzoxathiepine or one of its pharmaceutically acceptable salts for the treatment of cancer and in particular in the prevention and / or treatment of cancer metastases.
priorityDate 2011-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02081464-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69652579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425115491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415758420
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428199565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421212537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425035971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447566935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11174599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID450473
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422160756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413909092
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16790
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56959
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552268
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449497277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69978179

Total number of triples: 53.